Catherine Vilchèze - Concepedia

Author

Catherine Vilchèze

Albert Einstein College of Medicine ORCID

Also Known As

C. VILCHEZE, C. Vilcheze, C. Vilchèze, Catherine Vilcheze, Catherine Vilchèze, Catherine Vilchèze, Catherine Vilchéze

106

Publications

9.1K

Citations

H-Index

Concepts

All Affiliations

Albert Einstein College of Medicine Howard Hughes Medical Institute Texas A&M University Rutgers, The State University of New Jersey Rutgers New Jersey Medical School

About

Catherine Vilchèze is an author at Albert Einstein College of Medicine specializing in medicine, microbiology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	30	3.4K
2	Biochemistry	22	22	2.2K
3	Natural Sciences	14	14	1.2K
4	Health Sciences	6	6	874
5	Engineering	1	1	158

Catherine Vilchèze

Publications

7.6K

Citations

H-Index

Page 1

	Year	Citations
Effect of the Structure of Natural Sterols and Sphingolipids on the Formation of Ordered Sphingolipid/Sterol Domains (Rafts) Xiaolian Xu, Robert Bittman, Guy Duportail, Journal of Biological Chemistry	2001	527
Enzymic Characterization of the Target for Isoniazid in Mycobacterium tuberculosis James C. Sacchettini, Andréa Dessen, Catherine Vilchèze, Biochemistry	1995	368
Mycobacterium tuberculosis is extraordinarily sensitive to killing by a vitamin C-induced Fenton reaction Catherine Vilchèze, Travis Hartman, Brian Weinrick, Nature Communications Pulmonary TuberculosisMedicineMycobacterium TuberculosisTuberculosisToxicology	2013	328
Auranofin exerts broad-spectrum bactericidal activities by targeting thiol-redox homeostasis Michael B. Harbut, Catherine Vilchèze, Xiaozhou Luo, Proceedings of the National Academy of Sciences	2015	324
Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid Catherine Vilchèze, Feng Wang, Masayoshi Arai, Nature Medicine Pulmonary TuberculosisPathogenesisTuberculosis PreventionMolecular BiologyPoint Mutation	2006	321
The Fatty Acid Biosynthesis Enzyme FabI Plays a Key Role in the Development of Liver-Stage Malarial Parasites Min Yu, T. R. Santha Kumar, Louis J. Nkrumah, Cell Host & Microbe BiologyBiosynthesisKey RoleBiochemistryNatural Sciences	2008	312
Crystal Structure of the Mycobacterium tuberculosis Enoyl-ACP Reductase, InhA, in Complex with NAD+ and a C16 Fatty Acyl Substrate Denise A. Rozwarski, Catherine Vilchèze, Michele Sugantino, Journal of Biological Chemistry	1999	286
Altered NADH/NAD <sup>+</sup> Ratio Mediates Coresistance to Isoniazid and Ethionamide in Mycobacteria Catherine Vilchèze, Torin R. Weisbrod, Bing Chen, Antimicrobial Agents and Chemotherapy Intracellular Nadh/nadBacteriologyMolecular BiologyMicrobial PhysiologyNadh Levels	2005	279
Inactivation of the <i>inhA</i> -Encoded Fatty Acid Synthase II (FASII) Enoyl-Acyl Carrier Protein Reductase Induces Accumulation of the FASI End Products and Cell Lysis of <i>Mycobacterium smegmatis</i> Catherine Vilchèze, Héctor R. Morbidoni, Torin R. Weisbrod, Journal of Bacteriology	2000	278
Pyrazinamide inhibits the eukaryotic-like fatty acid synthetase I (FASI) of Mycobacterium tuberculosis Oren Zimhony, Jeffery S. Cox, John T. Welch, Nature Medicine Pulmonary TuberculosisBiosynthesisBiochemistryMycobacterium TuberculosisTuberculosis	2000	260

Page 1